Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results

被引:72
作者
Hudson, Henry L.
Lane, Stephen S.
Heier, Jeffrey S.
Stulting, R. Doyle
Singerman, Lawrence
Lichter, Paul R.
Sternberg, Paul
Chang, David F.
机构
[1] Retina Ctr, Tucson, AZ USA
[2] Associated Eye Care, Stillwater, MN USA
[3] Ophthalm Consultants Boston, Boston, MA USA
[4] Emory Univ, Ctr Eye, Atlanta, GA 30322 USA
[5] Retina Associates Cleveland, Beachwood, OH USA
[6] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA
[7] Vanderbilt Univ, Inst Eye, Nashville, TN USA
[8] Altos Eye Phys, Los Altos, CA USA
关键词
D O I
10.1016/j.ophtha.2006.07.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the safety and efficacy of an implantable visual prosthetic device (IMT; VisionCare Ophthalmic Technologies, Saratoga, CA) in patients with bilateral, end-stage age-related macular degeneration (AMD). Design: Prospective, open-label, multicenter clinical trial with fellow eye controls. Participants: A total of 217 patients (mean age, 76 years) with AMD and moderate to profound bilateral central visual acuity loss (20/80-20/800) resulting from bilateral untreatable geographic atrophy, disciform scars, or both were enrolled. Methods: A visual prosthetic device (implantable telescope), designed to enlarge retinal images of the central visual field, was implanted monocularly in the capsular bag after lens extraction. Fellow eyes were not implanted to provide peripheral vision and served as controls. Study patients participated in 6 visual rehabilitation visits after surgery. Main Outcome Measures: Best-corrected distance visual acuity (BCDVA) and best-corrected near visual acuity (BCNVA), quality-of-life scores from the National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) and the Activities of Daily Life scale, endothelial cell density (ECD), and incidence of complications and adverse events. Results: At 1 year, 67% of implanted eyes achieved a 3-line or more improvement in BCDVA versus 13% of fellow eye controls (P < 0.0001). Fifty-three percent of implanted eyes achieved a 3-line or more improvement in both BCDVA and BCNVA versus 10% of fellow eyes (P<0.0001). Mean BCDVA and BCNVA improved 3.5 lines and 3.2 lines, respectively, in implanted eyes versus 0.8 lines and 1.8 lines, respectively, in fellow eyes (P<0.0001). Change in visual acuity was not related to lesion type. Mean NEI VFQ-25 scores improved by more than 7 points from baseline (P < 0.01) on 7 of 8 relevant subscales. Eleven eyes did not receive the device because of an aborted procedure. Endothelial cell density was reduced by 20% at 3 months and 25% at 1 year. The decrease in ECD was correlated with postsurgical edema (P < 0.0001), and there was no evidence that endothelial cell loss is accelerated by ongoing endothelial trauma after implantation. Conclusions: This implantable visual prosthesis can improve visual acuity and quality of life in patients with moderate to profound visual impairment caused by bilateral, end-stage AMD. (c) 2006 by the American Academy of Ophthalmology.
引用
收藏
页码:1987 / 2001
页数:15
相关论文
共 45 条
[1]  
ADAMS E, 2003, VA TECHNOLOGY ASSESS
[2]   Cataract surgery in patients with age-related macular degeneration - One-year outcomes [J].
Armbrecht, AM ;
Findlay, C ;
Aspinall, PA ;
Hill, AR ;
Dhillon, B .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2003, 29 (04) :686-693
[3]   Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment [J].
Armbrecht, AM ;
Findlay, C ;
Kaushal, S ;
Aspinall, P ;
Hill, AR ;
Dhillon, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (12) :1343-1348
[4]   Effect of incision size and site on corneal endothelial changes in cataract surgery [J].
Beltrame, G ;
Salvetat, ML ;
Driussi, G ;
Chizzolini, M .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2002, 28 (01) :118-125
[5]  
Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198
[6]   Effect of cataract surgery on the corneal endothelium - Modern phacoemulsification compared with extracapsular cataract surgery [J].
Bourne, RRA ;
Minassian, DC ;
Dart, JKG ;
Rosen, P ;
Kaushal, S ;
Wingate, N .
OPHTHALMOLOGY, 2004, 111 (04) :679-685
[7]  
Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779
[8]  
Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621
[9]   Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration [J].
Brown, GC ;
Brown, MM ;
Sharma, S .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2000, 35 (03) :127-133
[10]   Age-related macular degeneration: economic burden and value-based medicine analysis [J].
Brown, MM ;
Brown, GC ;
Stein, JD ;
Roth, Z ;
Campanella, J ;
Beauchamp, GR .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2005, 40 (03) :277-287